Ageing population, air pollution to lift asthma meds uptake

The asthma medicines market is set to grow with incoming biologics and climbing disease rates, say market researchers
The asthma therapeutics market in the Asia-Pacific region is expected to grow from $4.1 billion in 2016 to around $6 billion by 2023, according to business intelligence provider GBI Research.
“The large size of the market is driven by high prevalence rates, particularly among children and the ageing population; the need for long-term reliever and maintenance medication; and the expected launch of high-cost biological therapies,” explains GBI Research in its latest report.....

Read more here: ajp.com.au

------------------------------------------------------

Something fishy: Indians swallow live fish for asthma
The wriggling five-centimetre murrel fish are slipped into the throats of patients in a bizarre treatment that leaves them gagging.
HYDERABAD: More than 5,000 Indians have lined up in the country’s south, pinching their noses and sticking their tongues out to swallow live fish in an unusual traditional treatment for asthma.
Every year in June asthma patients gather in the southern city of Hyderabad to gulp down the fish stuffed with a yellow herbal paste, hoping it will help them breathe more easily.....

Read more here: freemalaysiatoday.com

------------------------------------------------------

Short-term benefits for immunotherapy in allergic asthma

(HealthDay)—Administration of allergen immunotherapy (AIT) in patients with allergic asthma leads to lower short-term symptom and medication scores, according to a review published online May 19 in Allergy.
Sangeeta Dhami, M.B.B.S., from Evidence-Based Health Care in Edinburgh, U.K., and colleagues performed a systematic review to examine evidence on the effectiveness, cost-effectiveness, and safety of AIT. Data were reviewed from 98 studies.....

Read more here: medicalxpress.com